Convalescent Plasma for the Treatment of COVID-19
Clinical trial NCT04389710 · COMPLETED
Trial details
- NCT number
- NCT04389710
- Sponsor
- Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-15
- Primary completion
- 2020-11-03
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.